Select a Size
About This Item
biological source
rabbit
Quality Segment
recombinant
expressed in HEK 293 cells
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
1J6, recombinant monoclonal
description
recombinant, expressed in HEK 293 cells
product line
ZooMAb® learn more
form
lyophilized
mol wt
calculated mol wt 38.07 kDa, observed mol wt ~53 kDa
purified by
using Protein A
species reactivity
mouse, human, rat
packaging
antibody small pack of 25
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
sustainability
Sustainability features
technique(s)
affinity binding assay: suitable, immunocytochemistry: suitable, western blot: suitable
isotype
IgG
epitope sequence
C-terminal half
Protein ID accession no.
UniProt accession no.
shipped in
ambient
storage temp.
2-8°C
Gene Information
human ... HOXC10(3226)
General description
Homeobox protein Hox-C10 (UniProt Q9NYD6; also known as Homeobox protein Hox-3I) is encoded by the HOXC10 (also known as HOX3I) gene (Gene ID: 3226) in human. HOXC10 belongs to a family of highly conserved homeobox transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, with HOXC genes located in a cluster on chromosome 12. Hox-C10 is also implicated to be involved in replication, where it binds in a structure-dependent manner to origins of replication and contributes to the assembly of replicative complexes. HOXC10 transcription is reported to be silenced in two estrogen deprivation-resistent cell lines, C4-12 and LTED, derived from MCF-7 breast cancer cells as a result of epigenetic hypermethylation as well as additional repressive histone modifications. Evidence indicates that Hox-C10 expression is repressed by estrogen in vitro and in vivo to promote tumor growth. Short-term estrogen withdrawal restores HOXC10 expression to induce growth arrest and apoptosis, but its long-term absence results in permanent repression as a result of epigenetic methylation and the development of estrogen-independent cancer cells. This ZooMAb® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.
Immunogen
Application
Evaluated by Western Blotting in human liver tissue lysate.
Western Blotting Analysis: A 1:10,000 dilution of this antibody detected HOXC10 in human liver tissue lysate.
Tested Applications
Western Blotting Analysis: A 1:10,000 dilution from a representative lot detected HOXC10 in lysates from mouse liver tissue and rat liver tissue.
Immunocytochemistry Analysis: A 1:1,000 dilution from a representative lot detected HOXC10 in HeLa cells.
Affinity Binding Assay: A representative lot of this antibody bound HOXC10 peptide with at least one thousand-fold (1,000X) higher affinity than with non-specific control peptide.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Biochem/physiol Actions
Physical form
Preparation Note
Legal Information
Disclaimer
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
11 - Combustible Solids
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.